Evidence map›Paper›PMID 41107933›Full record

ArticleRespiratory research2025

Oxidative stress triggers Itch-mediated TXNIP degradation and NF-κB activation promoting chronic obstructive pulmonary disease.

Pei-Yun Lin, Kang-Yun Lee, Shu-Chuan Ho, Hsiao-Chi Chuang, Bing-Hua Su, Ying-Jung Wu, Po-Chun Tseng, Tsung-Ting Tsai, Chiou-Feng Lin, Rahmat Dani Satria and 2 more

Abstract read
In one paragraph

Article in Respiratory research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Aberrant DNMTs Promote TXNIP Upregulation and Ovarian Fibrosis in PCOS.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  5. Article
  6. Article
  7. Profibrotic predictive toxicology in the lung.Frontiers in pharmacology · 2026
    Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Pei-Yun LinGraduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei , 110, Taiwan.
Kang-Yun LeeDivision of Pulmonary Medicine, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, New Taipei City, 235, Taiwan.
Shu-Chuan HoSchool of Respiratory Therapy, College of Medicine, Taipei Medical University, Taipei, 110, Taiwan.
Hsiao-Chi ChuangSchool of Respiratory Therapy, College of Medicine, Taipei Medical University, Taipei, 110, Taiwan.
Bing-Hua SuSchool of Respiratory Therapy, College of Medicine, Taipei Medical University, Taipei, 110, Taiwan.
Ying-Jung WuSchool of Respiratory Therapy, College of Medicine, Taipei Medical University, Taipei, 110, Taiwan.
Po-Chun TsengDepartment of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Tsung-Ting TsaiDepartment of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Chiou-Feng LinGraduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei , 110, Taiwan.
Rahmat Dani SatriaDepartment of Clinical Pathology and Laboratory Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, 55281, Indonesia.
Fu-Chia ShihSchool of Respiratory Therapy, College of Medicine, Taipei Medical University, Taipei, 110, Taiwan.
Chia-Ling ChenGraduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei , 110, Taiwan. chialing66@tmu.edu.tw.

Funding

National Science and Technology Council MOST 111-2314-B-038-120-MY3, NSTC 113-2320-B-038-003
6 · The paper itself

Abstract

backgroundChronic inflammatory lung diseases, including chronic obstructive pulmonary disease (COPD), are characterized by pulmonary structural changes, narrowing of the small airways, and destruction of the lung parenchyma caused by prolonged inflammation. Sustained inflammation mediated by macrophages is considered to play a critical role in COPD pathogenesis, while the inductive mechanisms of persistent inflammation remain unclear.

methodsIn vitro, RAW264.7 cells were treated with cigarette smoke extract (CSE), hydrogen peroxide, and 12-O-tetradecanoylphorbol-13-acetate. Loss-of-function assays were performed using MAPK inhibitors and Itch-specific knockdown. In vivo, lung tissues from mice exposed to whole-body cigarette smoke (CS) for 12 weeks, as well as clinical samples from healthy non-smokers, a healthy smoker, and COPD patients, were analyzed.

resultsOur findings demonstrated that thioredoxin-interacting protein (TXNIP) participates in CS-induced NF-κB activation in macrophages, which may contribute to pulmonary inflammation. CSE markedly inhibited TXNIP expression in RAW264.7 cells through MAPK-dependent regulation, accompanied by the induction of iNOS/NO and COX-2. The decrease in TXNIP was also detected in lung tissues and macrophages obtained from smoking mice, while higher NF-κB activation and lung inflammation occurred simultaneously. Additionally, CS-induced oxidative stress triggered MAPK-dependent proteasomal degradation of TXNIP, leading to subsequent NF-κB activation. The expression of E3 ligase Itch was elevated in smoking mouse lungs and in hydrogen peroxide-stimulated cells, whereas specific silencing Itch significantly attenuated TXNIP degradation as well as NF-κB activation. Moreover, Itch expression was increased in lung tissues, whereas TXNIP was markedly reduced in lung tissues, bronchoalveolar lavage fluid cells, and peripheral blood mononuclear cells from patients with COPD.

conclusionAccordingly, CS-induced oxidative stress promotes Itch-mediated TXNIP degradation, leading to NF-κB-driven inflammation in macrophages and potentially contributing to COPD pathogenesis.

Indexed as

Carrier ProteinsNF-kappa BOxidative StressPulmonary Disease, Chronic ObstructiveThioredoxinsUbiquitin-Protein LigasesAnimalsCell Cycle ProteinsFemaleHumansMaleMiceMice, Inbred C57BLMiddle AgedProteolysisRAW 264.7 CellsCarrier ProteinsCell Cycle ProteinsITCH protein, humanItch protein, mouseNF-kappa BRepressor ProteinsThioredoxinsTXNIP protein, humanTxnip protein, mouseUbiquitin-Protein LigasesCOPDItchNF-κBROSTXNIP

Identifiers

PMID41107933
PMCPMC12534957

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.